Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry
- 19 January 2010
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (4) , 339-346
Abstract
Objective: To describe demographic, genetic, and clinical characteristics of patients with neuronopathic Gaucher disease (NGD).Methods: All patients enrolled in the Neurological Outcomes Subregistry of the International Collaborative Gaucher Group (ICGG) Gaucher Registry as of June 2007 were identified.Results: The study cohort comprised 131 patients from 17 countries who were enrolled in the Neurological Outcomes Subregistry. The onset of neurological manifestations had occurred before 2 years of age in 47% (61 out of 131 patients), 2 years of age or older in 41% (54 out of 131), and could not be ascertained in the remaining 12% (16 out of 131). The most common manifestations were inability to look to the extreme up or down (45%, 55 out of 123), abnormally slow object tracking (43%, 53 out of 123), convergent squint (36%, 44 out of 121), and ataxia (15 to 20%, 18–27 out of 117). Seizures were reported in 19 out of 122 patients (16%), and myoclonic seizures were reported in 3 out of 121 patients (2%). The most common genotypes were L444P/L444P (76 out of 108, 70%), L444P/D409H (9 out of 108, 8%), D409H/D409H (8 out of 108, 7%), and L444P/rare allele (6 out of 108, 6%); full sequencing was not performed in all patients.Conclusions: Neurological manifestations of GD often begin to appear before the age of 2 years. The most common neurological signs and manifestations are brainstem abnormalities and fine motor dysfunction. The most common genotype is L444P/L444P.Keywords
This publication has 15 references indexed in Scilit:
- A severity scoring tool to assess the neurological features of neuronopathic Gaucher diseaseJournal of Inherited Metabolic Disease, 2007
- Gaucher disease among Chinese patients: Review on genotype/phenotype correlation from 29 patients and identification of novel and rare allelesBlood Cells, Molecules, and Diseases, 2007
- The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher diseaseClinical Genetics, 2007
- The Clinical and Demographic Characteristics of Nonneuronopathic Gaucher Disease in 887 Children at DiagnosisArchives of Pediatrics & Adolescent Medicine, 2006
- Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patientsJournal of Inherited Metabolic Disease, 2006
- Characterization of neuronopathic Gaucher disease among ethnic PolesGenetics in Medicine, 2006
- The Gaucher RegistryArchives of internal medicine (1960), 2000
- Enzyme replacement therapy in type III Gaucher diseaseJournal of Inherited Metabolic Disease, 1999
- Gaucher disease‐Norrbottnian type (III)Acta Paediatrica, 1986
- Gaucher disease-norrbottnian typeEuropean Journal of Pediatrics, 1980